The Few Bets That Matter
$ALAB had a strong quarter and is yet down ~20%.

I haven't seen quality coverage of this company on X and I believe it deserves one, so here is the complete analysis I shared with subscribers.

Review of the quarter, the reasons for the drop, how I think about it & what I do.

https://t.co/l9nGdNNrQu - The Few Bets That Matter
tweet

Benjamin Hernandez😎
Started an exclusive WhatsApp hub for international stock enthusiasts.
We analyze flows, forward alerts, spot opportunities ahead, and empower one another.

Daily strong selections from me.
Join the thrill ⚡ https://t.co/71FIJId47G

Msg "Profit" to enter now.
$SOFI $HOOD $PLTR

The "Smart Furniture" Alpha
Recommendation: $HTLM near $3.59

Audio-integrated sofas? Yes, and it's highly profitable. $HTLM is up +70.35% as their Zeica Labs partnership goes viral.

One-line why: They are creating a lifestyle ecosystem, not just selling chairs. https://t.co/gRUsRMprYx - Benjamin Hernandez😎
tweet

Dimitry Nakhla | Babylon Capital®
Sandisk is estimated to generate $76.34 EPS in 2027 and roughly $9.65B in FCF.

At ~$610 per share, $SNDK carries a market value near $90B.

That implies just ~8x 2027 EPS and ~9.3x FCF.

A potentially interesting setup if those forward estimates prove reasonably accurate. https://t.co/LHgKsj9kXU

$SNDK Incremental Operating Margins (QoQ)

Q3 2025→Q4 2025: ~9,495%*
Q4 2025→Q1 2026: 39%
Q1 2026→Q2 2026: 124%

Q2 2026 report, more than 100% of $SNDK incremental revenue converted into operating income

Operating leverage😮‍💨

*Operating income flipped negative to positive https://t.co/fqv5uzK8Ez - Dimitry Nakhla | Babylon Capital®
tweet

The Few Bets That Matter
$TMDX, my #1 position, will report earnings on February 24, in 13 days.

I see a revenue floor of ~$157M and hope to hear more about heart & lungs clinical trials which both have received unconditional aproval from the FDA, and about European expansion and opportunity as it should have started H1-26.

$TMDX is an ignored healthcare opportunity with a monster potential, and I expect this to be shown on FY26 guidance.

From my point of view, everything is positive on this name today, and should be after earnings.

$TMDX closed the quarter with 2,308 flights after a very strong finish to December.

I see a revenue floor of ~$157M (+29% YoY), putting FY25 slightly above $600M (+36% YoY).

Final numbers will depend on DCD/DBD mix, services and heart/lung trials, but overall I expect $TMDX to at least meet the midpoint of guidance - raised three times this year.

This assumes ~20% use of third-party transport, consistent with previous quarters and management’s targets. Any deviation would impact the math.

I am very positive on the company and look forward to what FY26 brings. Probably going to be great.
https://t.co/FThbpSovjv

I still consider the stock a steal at today's price. - The Few Bets That Matter
tweet

The Few Bets That Matter
RT @WealthyReadings: $QQQ & $SPY down, everything being sold today.

What's green?

$SLB 2.77%
$UPS 5.29%
$NTR 1.92%
$DAR 3.22%
$SWBI 3.75%

But no one cares. 👇

https://t.co/TVqbdhKTn4 - The Few Bets That Matter
tweet

Dimitry Nakhla | Babylon Capital®
RT @DimitryNakhla: AI has created extraordinary investment opportunities in AI leaders — while fear of AI disruption has 𝘴𝘪𝘮𝘶𝘭𝘵𝘢𝘯𝘦𝘰𝘶𝘴𝘭𝘺 created extraordinary investment opportunities in businesses viewed as being threatened by it.

A bit ironic, no?
tweet

The Few Bets That Matter
Last month I shared an article about FinX darlings I wouldn't buy. Fast forward to today.

$NFLX -10%
$ADBE -16%
$DUOL -26%
$PYPL -28%
$UBER -16%
$HIMS -44%

Violent.

I am a big fan of some of those companies. But it isn't enough to be a buyer.

Investing isn't cheerleading. https://t.co/n9LAg3cfxj

https://t.co/gymKiwJpsu - The Few Bets That Matter
tweet

Quiver Quantitative
JUST IN: Neguse questions Bondi on the elimination of the DOJ's cryptocurrency enforcement team https://t.co/oS3vhq9EPO
tweet